1. PTH-094 Indirect treatment comparison of ustekinumab versus other biologics in moderate to severe crohn's disease: a 1-year treatment sequence analysis. (17th June 2017) Authors: Pacou, M; Mesana, L; Gauthier, A; Naessens, D; Sloan, S; Danese, S; Bonovas, S; Abrams, K Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever. Issue 1 (December 2015) Authors: Horneff, G; Ruperto, N; Brunner, H; Quartier, P; Constantin, T; Alexeeva, E; Kone-Paut, I; Marzan, K; Wulffraat, N; Schneider, R; Padeh, S; Chasnyk, V; Wouters, C; Deschner, J; Kallinich, T; Lauwerys, B; Haddad, E; Nasonov, E; Trachana, M; Vougiouka, O Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab. Issue 1 (December 2015) Authors: Brogan, P; Hofer, M; Kuemmerle-Deschner, J; Lauwerys, B; Speziale, A; Abrams, K; Leon, K; Wei, X; Laxer, R Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab. Issue 1 (December 2015) Authors: Brogan, P; Hofer, M; Kuemmerle-Deschner, J; Lauwerys, B; Speziale, A; Abrams, K; Leon, K; Wei, X; Laxer, R Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever. Issue 1 (December 2015) Authors: Horneff, G; Ruperto, N; Brunner, H; Quartier, P; Constantin, T; Alexeeva, E; Kone-Paut, I; Marzan, K; Wulffraat, N; Schneider, R; Padeh, S; Chasnyk, V; Wouters, C; Deschner, J; Kallinich, T; Lauwerys, B; Haddad, E; Nasonov, E; Trachana, M; Vougiouka, O Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics of Canakinumab in children younger than 2 years old with CAPS. Issue 1 (December 2015) Authors: Kalabus, J; Brogan, P; Hofer, M; Kuemmerle-Deschner, J; Lauwerys, B; Speziale, A; Laxer, R; Sun, H; Abrams, K; Leon, K; Junge, G Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Does patient knowledge affect the colorectal cancer risk in ulcerative colitis?. Issue 924 (1st October 2002) Authors: Eaden, J A; Abrams, K; Mayberry, J F Journal: Postgraduate medical journal Issue: Volume 78:Issue 924(2002) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0511 Secukinumab demonstrates consistent safety over long-term exposure in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses. (15th June 2017) Authors: Mease, PJ; McInnes, IB; Reich, K; Nash, P; Andersson, M; Abrams, K; Pricorp, L; Fox, T Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗